The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...

With more and more people signing up for weight loss drugs, the potential side effects are starting to attract attention.

The diet company formerly known as WeightWatchers has filed for bankruptcy after its 62-year-old business model was put under ...

The company has seen sales hit by alternative compounded versions of its blockbuster weight-loss and diabetes drugs, ...

The company, which has shaped how millions eat and exercise, is trying to reduce its debt as it expands its telehealth ...

As weight-loss injectables like Ozempic skyrocket in popularity, a new offshoot trend is starting to take hold: microdosing. But experts have concerns.

Novo Nordisk now expects sales to grow 13% to 21% in constant currencies this year, from 16% to 24% previously. Operating profit should grow 16% to 24% compared with a previous target of 19% to 27%.

The weight loss company will focus on its transition into a telehealth service that helps users get prescriptions for drugs ...

Shares of the company, which once boasted of media mogul Oprah Winfrey as one of its top shareholders, slumped 40% in ...

I t’s hard to overstate just how revolutionary the development of medications like Ozempic and Wegovy has been for managing ...

Hims & Hers Health, Inc.'s subscriber growth, Novo Nordisk partnership, and FDA pill approval could boost financials. Click ...

With anti-obesity injections dominating conversations, it's no surprise the conversation around their impact is growing. A ...